Utilize este identificador para referenciar este registo:
|Título:||Further evidence of novel APOB mutations as a cause of familial hypercholesterolaemia|
|Autor:||Alves, Ana Catarina|
Medeiros, Ana Margarida
Doenças Cardio e Cérebro-vasculares
|Citação:||Atherosclerosis. 2018 Oct;277:448-456. doi: 10.1016/j.atherosclerosis.2018.06.819.|
|Resumo:||APOB mutations are a rare cause of familial hypercholesterolaemia (FH) and, until recently, routine genetic diagnosis only included the study of two small APOB fragments. In previous years, 5 novel functional mutations have been described in APOB fragments not routinely studied, our group having functionally characterized 2 of them. The main aim of this work was to identify and characterize novel alterations in APOB to assess the genetic cause of hypercholesterolemia in patients with a clinical diagnosis of FH.|
Highlights: The spectrum of functional alterations in APOB outside the fragments routinely screened is growing; We characterized two rare novel variants in APOB, p.(Thr3826Met) is pathogenic and p.(Pro994Leu) is neutral; The study of all 29 exons of APOB should be performed in routine diagnosis, now possible by NGS, since it is expected that a further 5–10% of clinical FH patients can have FH due to a novel APOB mutation; Due to low penetrance of APOB variants and high rate of common variants inAPOB, all novel variants need to be functionally characterized to prove their pathogenicity.
|Versão do Editor:||https://doi.org/10.1016/j.atherosclerosis.2018.06.819|
|Aparece nas colecções:||DPSPDNT - Artigos em revistas internacionais|
Ficheiros deste registo:
|Further evidence of novel APOB mutations as a cause of familial.pdf||685,45 kB||Adobe PDF||Ver/Abrir Acesso Restrito. Solicitar cópia ao autor!|
Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.